Page 141 - Pagetit

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE

Pickworth WB, Heishman SJ, Henningfield JE (1995) Relationships between EEG
and performance during nicotine withdrawal and administration. Brain Imaging
of Nicotine and Tobacco Smoking. Ann Arbor, MI, NPP Books:1–13.
Piomelli D et al. (1999) Structural determinants for recognition and translocation
by the anandamide transporter. Proceedings of the National Academy of Science
of the United States of America, 96:5802–5807.
Platt DM, Rowlett JK, Spealman RD (2001) Discriminative stimulus effects of
intravenous heroin and its metabolites in rhesus monkeys: opioid and
dopaminergic mechanisms. Journal of Pharmacology and Experimental
Therapeutics, 299:760–767.
Pope HG Jr, Gruber AJ, Yurgelun-Todd D (1995) The residual neuropsychological
effects of cannabis: the current status of research. Drug and Alcohol Dependence,
38:25–34.
Reggio PH, Traore H (2000) Conformational requirements for endocannabinoid
interaction with the cannabinoid receptors, the anandamide transporter and fatty
acid amidohydrolase. Chemistry and Physics of Lipids, 108:15–35.
Rehm J et al. (2001) Feasibility, safety, and efficacy of injectable heroin prescription
for refractory opioid addicts: a follow-up study. Lancet, 358:1417–1420.
Riegel AC, French ED (1999) An electrophysiological analysis of rat ventral
tegmental dopamine neuronal activity during acute toluene exposure.
Pharmacology and Toxicology, 85:37–43.
Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at
dopamine, norepinephrine and serotonin transporters: a structure–activity study.
Life Sciences, 46:635–645.
Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced
by chronic amphetamine administration: a review and evaluation of animal
models of amphetamine psychosis. Brain Research Reviews, 11:157–198.
Rocha BA et al. (1998) Cocaine self-administration in dopamine-transporter
knockout mice. Nature Neuroscience, 1:132–137.
Rodriguez de Fonseca F et al. (1997) Activation of corticotropin-releasing factor
in the limbic system during cannabinoid withdrawal. Science, 276:2050–2054.
Rogers RD, Robbins TW (2001) Investigating the neurocognitive deficits associated
with chronic drug misuse. Current Opinion in Neurobiology, 11:250–257.
Rose JE, Behm FM, Levin ED (1993) Role of nicotine dose and sensory cues in the
regulation of smoke intake. Pharmacology, Biochemistry and Behavior, 44:891–
900.
Rosecrans JA, Karan LD (1993) Neurobehavioral mechanisms of nicotine action:
role in the initiation and maintenance of tobacco dependence. Journal of
Substance Abuse Treatment, 10:161–170.
Rothman RB, Glowa JR (1995) A review of the effects of dopaminergic agents on
humans, animals, and drug-seeking behavior, and its implications for medication
development: focus on GBR12909. Molecular Neurobiology, 11:1–19.
Royal College of Physicians (2000) Nicotine addiction in Britain: a report of the
Tobacco Advisory Group of the Royal College of Physicians. London, Royal College
of Physicians.

120

Chapter_4 120 19.1.2004, 11:44